Type
. Hepatotoxicity of the combination of rifampin-ethionamide in the treatment of multibacillary leprosy. International journal of leprosy and other mycobacterial diseases : official organ of the International Leprosy Association. 1984;52(1):1-6.
Type
. Parasitism of antigen presenting cells in hyperbacillary leprosy. Clinical and experimental immunology. 1984;55(3):611-7.
Type
. Defective production of monocyte-activating cytokines in lepromatous leprosy. The Journal of experimental medicine. 1984;159(3):666-78.
Type
. In vitro studies on the effect of levamisole in lepromatous leprosy. Journal of clinical & laboratory immunology. 1984;13(2):93-6.
Type
. East-West efforts key into leprosy research. JAMA. 1984;251(1):15-8.
Type
. Immunization against leprosy: progress and prospects. Bulletin of the World Health Organization [Internet]. 1984;62(1):1-6. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2536277/pdf/bullwho00090-0014.pdf
Type
. An alternative route for infecting armadillos with Mycobacterium leprae. Microbios. 1984;39(156):83-6.
Type
. An attempt to inoculate Mycobacterium leprae into 'rhino' mice. Experimental cell biology. 1984;52(1-2):150-3.
Type
. Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3. Clinical and experimental immunology [Internet]. 1984;55(1):140-8. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1535784/pdf/clinexpimmunol00148-0149.pdf
Type
. Evaluation of Mycobacterium leprae immunogenicity via adoptive transfer studies. Infection and immunity. 1984;43(1):79-83.
Pagination
- Previous page
- Page 1126
- Next page